TRI is pleased to announce that the GARFIELD-AF Risk Calculator is now available freely for clinicians globally on iOS and Android devices. The tool predicts risk of stroke, bleeding and death in patients over two years on three different treatment courses.
TRI worked closely with QxMD to develop a version hosted by the Calculate by QxMD app.
https://qxcalc.app.link/garfield-af.
The tool was validated in a recent study in a Danish population, confirming the tool is superior to CHA2DS2VASc in predicting stroke/SE and comparable with HAS-BLED for predicting major bleeding.
Utility:
– rapidly predicts differences in risk when treated with different anticoagulants or not treated
– uses patient-specific measurements rather than standardised measures, providing personalised results
– underscored by data of 52,000 AF patients and externally validated